Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis

Experimental and Molecular Pathology

Volumn 83, Issue 2, 2007, Pages 198-206

  Cudrici, Cornelia ^a   Ito, Takahiro ^a   Zafranskaia, Ekaterina ^a   Niculescu, Florin ^a   Mullen, Katherine M ^b   Vlaicu, Sonia ^a   Judge, Susan I V ^a,c   Calabresi, Peter A ^b   Rus, Horea ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VAMHCS   (United States)

Author keywords

Dendritic cells; Macrophages; Multiple sclerosis; Non lesional gray matter; T lymphocytes

Indexed keywords

BIOLOGICAL MARKER; CD205 ANTIGEN; CD209 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CCR7; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; ANTIGEN EXPRESSION; ARTICLE; BIOACCUMULATION; CELL LABELING; CELLULAR DISTRIBUTION; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FEMALE; FROZEN SECTION; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE; MALE; MULTIPLE SCLEROSIS; PARENCHYMA; PROTEIN EXPRESSION; VASCULARIZATION; WHITE MATTER;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTOPSY; BRAIN; DENDRITIC CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MULTIPLE SCLEROSIS; PERIAQUEDUCTAL GRAY; RECEPTORS, CHEMOKINE;

EID: 34548250519     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.05.006     Document Type: Article

References (48)

1. Agosta F., Rovaris M., Pagani E., Sormani M.P., Comi G., and Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 129 (2006) 2620-2627
2. Allen I.V., and McKeown S.R. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J. Neurol. Sci. 41 (1979) 81-91
3. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., Aloisi F., and Coccia E.M. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64 (2005) 706-715
4. Bailey S.L., Carpentier P.A., McMahon E.J., Begolka W.S., and Miller S.D. Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26 (2006) 149-188
5. Bailey S.L., Schreiner B., McMahon E.J., and Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8 (2007) 172-180
6. Cudrici C., Niculescu T., Niculescu F., Shin M.L., and Rus H. Oligodendrocyte cell death in pathogenesis of multiple sclerosis: protection of oligodendrocytes from apoptosis by complement. J. Rehabil. Res. Dev. 43 (2006) 123-132
7. Dijkstra I.M., de Haas A.H., Brouwer N., Boddeke H.W., and Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 54 (2006) 861-872
8. Filippi M., Campi A., Dousset V., Baratti C., Martinelli V., Canal N., Scotti G., and Comi G. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45 (1995) 478-482
9. Fischer H.G., and Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166 (2001) 2717-2726
10. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., and Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005) 328-334
11. Gutcher I., and Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117 (2007) 1119-1127
12. Hauser S.L., and Oksenberg J.R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52 (2006) 61-76
13. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., Waisman A., Rulicke T., Prinz M., Priller J., Becher B., and Aguzzi A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11 (2005) 146-152
14. Hussien Y., Sanna A., Soderstrom M., Link H., and Huang Y.M. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. J. Neuroimmunol. 121 (2001) 102-110
15. Kato M., McDonald K.J., Khan S., Ross I.L., Vuckovic S., Chen K., Munster D., MacDonald K.P., and Hart D.N. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int. Immunol. 18 (2006) 857-869
16. Kivisakk P., Mahad D.J., Callahan M.K., Sikora K., Trebst C., Tucky B., Wujek J., Ravid R., Staugaitis S.M., Lassmann H., and Ransohoff R.M. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55 (2004) 627-638
17. Kostulas N., Li H.L., Xiao B.G., Huang Y.M., Kostulas V., and Link H. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33 (2002) 1129-1134
18. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., and Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 (2005) 2705-2712
19. Lin C.L., Suri R.M., Rahdon R.A., Austyn J.M., and Roake J.A. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 28 (1998) 4114-4122
20. Ma-Krupa W., Jeon M.S., Spoerl S., Tedder T.F., Goronzy J.J., and Weyand C.M. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J. Exp. Med. 199 (2004) 173-183
21. Matyszak M.K., and Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74 (1996) 599-608
22. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., and Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11 (2005) 335-339
23. McMahon E.J., Bailey S.L., and Miller S.D. CNS dendritic cells: critical participants in CNS inflammation?. Neurochem. Int. 49 (2006) 195-203
24. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J. Comp. Neurol. 405 (1999) 553-562
25. Mullen K.M., Rozycka M., Rus H., Hu L., Cudrici C., Zafranskaia E., Pennington M.W., Johns D.C., Judge S.I., and Calabresi P.A. Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann. Neurol. 60 (2006) 118-127
26. Neumann H., Medana I.M., Bauer J., and Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25 (2002) 313-319
27. Niculescu T., Weerth S., Niculescu F., Cudrici C., Rus V., Raine C.S., Shin M.L., and Rus H. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J. Immunol. 172 (2004) 5702-5706
28. Pahuja A., Maki R.A., Hevezi P.A., Chen A., Verge G.M., Lechner S.M., Roth R.B., Zlotnik A., and Alleva D.G. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses. Scand. J. Immunol. 64 (2006) 361-369
29. Pashenkov M., Huang Y.M., Kostulas V., Haglund M., Soderstrom M., and Link H. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124 (2001) 480-492
30. Pashenkov M., Teleshova N., Kouwenhoven M., Kostulas V., Huang Y.M., Soderstrom M., and Link H. Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clin. Exp. Immunol. 127 (2002) 519-526
31. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50 (2001) 389-400
32. Platten M., and Steinman L. Multiple sclerosis: trapped in deadly glue. Nat. Med. 11 (2005) 252-253
33. Plumb J., Armstrong M.A., Duddy M., Mirakhur M., and McQuaid S. CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions. Mult. Scler. 9 (2003) 142-147
34. Reichmann G., Schroeter M., Jander S., and Fischer H.G. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J. Neuroimmunol. 129 (2002) 125-132
35. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev., Immunol. 6 (2006) 476-483
36. Rus H., Pardo C.A., Hu L., Darrah E., Cudrici C., Niculescu T., Niculescu F., Mullen K.M., Allie R., Guo L., Wulff H., Beeton C., Judge S.I., Kerr D.A., Knaus H.G., Chandy K.G., and Calabresi P.A. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11094-11099
37. Sanna A., Fois M.L., Arru G., Huang Y.M., Link H., Pugliatti M., Rosati G., and Sotgiu S. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 143 (2006) 357-362
38. Schreiner B., Mitsdoerffer M., Kieseier B.C., Chen L., Hartung H.P., Weller M., and Wiendl H. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155 (2004) 172-182
39. Serafini B., Columba-Cabezas S., Di Rosa F., and Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157 (2000) 1991-2002
40. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., and Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65 (2006) 124-141
41. Soilleux E.J., Morris L.S., Leslie G., Chehimi J., Luo Q., Levroney E., Trowsdale J., Montaner L.J., Doms R.W., Weissman D., Coleman N., and Lee B. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71 (2002) 445-457
42. Solanilla A., Grosset C., Lemercier C., Dupouy M., Mahon F.X., Schweitzer K., Reiffers J., Weksler B., and Ripoche J. Expression of Flt3-ligand by the endothelial cell. Leukemia 14 (2000) 153-162
43. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2 (2001) 762-764
44. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
45. Ulvestad E., Williams K., Bjerkvig R., Tiekotter K., Antel J., and Matre R. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol. 56 (1994) 732-740
46. Valsasina P., Benedetti B., Rovaris M., Sormani M.P., Comi G., and Filippi M. Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Neurology 65 (2005) 1126-1128
47. Whartenby K.A., Calabresi P.A., McCadden E., Nguyen B., Kardian D., Wang T., Mosse C., Pardoll D.M., and Small D. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16741-16746
48. Zozulya A.L., Reinke E., Baiu D.C., Karman J., Sandor M., and Fabry Z. Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1{alpha} chemokine and matrix metalloproteinases. J. Immunol. 178 (2007) 520-529